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Microglial Cells Internalize Aggregates of
the Alzheimer’s Disease Amyloid b-Protein
Via a Scavenger Receptor
Donata M. Paresce,*†‡ Richik N. Ghosh,*‡ the pathogenesis of CNS disease, such as proteases
and cytotoxic agents that induce death of neurons andand Frederick R. Maxfield,‡§
demyelination of oligodendrocytes (Elkabes et al., 1996;*Pathology Department
Giulian, 1987; Giulian and Baker, 1986; McGeer et al.,†Biology Department
1993; Meda et al., 1995).‡Alzheimer’s Disease Research Center and
The presence of activated microglia within amyloidCenter for Neurobiology and Behavior
plaque cores suggests that these cells may either di-Columbia University
rectly contribute to the pathology of AD or they mayNew York, New York 10032
exacerbate an already preexisting problem. This may§Biochemistry Department
occur through several possible mechanisms: first, mi-Cornell University Medical College
croglia may directly contribute to amyloidosis by partici-New York, New York 10021
pating in the formation of Ab fibrils; second, microglia
may normally be engaged in phagocytosis of amyloid
fibers or aggregates, but in AD brains, microglia maySummary
fail to clear Ab protein and thus cause a build-up of the
protein that aggregates into large plaques; and third,Microglia are immune system cells associated with
Ab may activate microglia and trigger the productionAlzheimer’s disease plaques containing b-amyloid
of proinflammatory and potentially cytotoxic mediators.(Ab). Murine microglia internalize microaggregates of
Because microglia are the main inflammatory responsefluorescently labeled or radioiodinated Ab peptide
cells of the brain and activated microglia are enriched1–42. Uptake was confirmed using aggregates of unla-
around amyloid plaques, the microglia could make thebeled Ab detected by immunofluorescence. Uptake of
areas around the plaques sites of chronic inflammationAb was reduced by coincubation with excess acetyl–
(Araujo and Cotman, 1992; Giulian, 1987; Meda et al.,low density lipoprotein (Ac–LDL) or other scavenger
1995).receptor (SR) ligands, and DiI-labeled Ac–LDL uptake
There is substantial evidence supporting the hypothe-by microglia was blocked by excess Ab. CHO cells
sis that progressive cerebral accumulation of the amy-transfected with class A or B SRs showed significantly
loid b-protein is an early and perhaps necessary featureenhanced uptake of Ab. These results show that mi-
of the disease. Several AD-linked mis-sense mutationscroglia express SRs that may play a significant role in
in the bAPP have been shown in cell culture (Citron etthe clearance of Ab plaques. Binding to SRs could
al., 1992, 1994; Suzuki et al., 1994) or in a transgenic
activate inflammation responses that contribute to the
mouse model (Games et al., 1995) to increase the cellular
pathology of Alzheimer’s disease.
production of Ab. Also, the recently cloned S182 gene
that is responsible for the most common form of early-
Introduction onset AD appears, on the basis of initial data, to lead
to elevated cellular production of Ab (particularly the Ab
Alzheimer’s disease (AD) is a progressive neurodegener- 1–42 form) as measured in plasma and the conditioned
ative disease characterized by the presence of numer- medium of cultured fibroblasts (Querfurth et al., 1995).
ous senile plaques in the brain tissue, particularly in the Progressive deposition of Ab in the brain seems to pre-
hippocampus and cerebral cortex (Selkoe, 1991). There cede the onset of dementia by many years, and amyloid
are two types of senile plaques: dense core plaques, deposits are frequently surrounded by damaged neu-
which consist principally of extracellular fibrillar aggre- rons and reactive microglia.
gates, and diffuse plaques. The major component of However, not all AD cases that result from mutations
the dense plaques is b-amyloid (Ab), a 39–43 residue of APP are attributable to an overproduction of Ab (Cai
fragment of a larger membrane-spanning glycoprotein et al., 1993; Shaffer et al., 1995). The increase in Ab
called b-amyloid precursor protein (bAPP) (Haass and plaques in AD brains could be due to several factors,
Selkoe, 1993). In thebrains of patients with AD, activated such as an increase in cellular production, an increase
microglia are associated with virtually every amyloid in the stability of Ab aggregates or fibrils, or a decrease
deposit and are concentrated in regions of compact in the normal clearance of Ab peptides or aggregates.
amyloid deposits (Dickson et al., 1993), where they sur- Ab isolated from senile plaques is hydrophobic, has
round and infiltrate into the b-amyloid plaques (Wegiel limited solubility even in strongly denaturing aqueous
and Wisniewski, 1990). solvents and is resistant to crude collagenase (Glenner
Very little is known, however, about the function of and Wong, 1984) and pepsin (Masterset al., 1985) diges-
the microglia surrounding the plaques or the nature of tion. Ab peptides form antiparallel b-pleated sheets that
the interaction between plaque proteins and the micro- aggregate into 7.5–10 nm fibrils that, by x-ray diffraction,
glia. It is well documented that resident resting microglia have a cross b-sheet conformation. Synthetic peptides
are activated in response to injury, infection, and inflam- corresponding to Ab can also spontaneously form amy-
mation of the nervous system. Activated microglia prolif- loid-like fibrils in a b-sheet conformation (Burdick et al.,
erate, exhibit phagocytic activity removing infectious 1992; Castano et al., 1986; Gorevic et al., 1987; Kirschner
agents or remnants of dying brain tissue, and produce et al., 1986, 1987). The normal mechanisms of degrada-
tion of Ab in the brain are not known.a number of secreted factors that may be involved in
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The close association of microglia with Ab inAD brains Abs, which are a minor component of the Ab in human
suggests that receptors might be involved in the interac- cerebrospinal fluid and plasma, are critically important
tion. Receptor interactions would be important in pro- in AD, where they deposit selectively in all types of senile
moting endocytic or phagocytic clearance of Ab, but plaques (Gravina et al., 1995), and that most of the Ab
there has been no characterization of receptors that in isolated senile plaque cores ends at Ab 42 (Roher et
promote binding of Ab fibrils or aggregates. It has been al., 1993a, 1993b), we used synthetic Ab 1–42 in our
reported that ameboid microglia found in spinal cord experiments to model AD amyloid plaque in vitro.
and brain have several morphologic or functional prop- To characterize the macromolecular assemblies
erties in common with macrophages. They are able to formed by the synthetic Ab 1–42 under our experimental
engulf 5 mm latex beads (Giulian, 1987) and contain the conditions, the structures formed by synthetic Ab 1–42
macrophage surface receptors MAC-1, (aMb2 integrin) in pH 7.4 labeling medium were observed by light and
(Akiyama and McGeer, 1990; Giulian, 1987; Perry et al., electron microscopy and compared with Ab 1–42 fibrils
1985), MAC-3 (Giulian and Baker, 1986), and immuno- formed in pH 5 medium. Negative stain electron micros-
globulin Fc receptors (Akiyama and McGeer, 1990). Un- copy of structures formed by Cy3-labeled Ab (Figures
like astroglia or oligodendroglia, they also have the 1c and 1d) and unmodified Ab (data not shown) revealed
capacity to bind and internalize acetyl–low density lipo- aggregates with diameters of up to several microns (Fig-
protein (Ac–LDL) (Giulian, 1987; Giulian and Baker, ure 1c). At higher magnification, small fibrils with diame-
1986). In mouse peritoneal macrophages, scavenger re- ters of z10 nm were present within aggregates (Figure
ceptors (SRs) have been shown to mediate the high 1d). The fibrillar morphology was typical of amyloid ag-
affinity binding of Ac–LDL and its internalization and gregates induced in vitro (Burdick et al., 1992). Consis-
lysosomal degradation, and this binding can be inhibited tent with the electron microscopic data, observations
by a wide variety of compounds in a simple competition of aggregates using fluorescence microscopy indicated
assay (Goldstein et al., 1979; Krieger et al., 1993). Macro- that dilution of Ab 1–42 into HEPES-buffered labeling
phage SR ligands include certain types of chemically medium yields a mixture of mostly small aggregates that
modified proteins such as Ac–LDL, oxidized LDL, and appeared as point sources by fluorescence microscopy
maleylated bovine serum albumin (M-BSA) (but not their (microaggregates, size < 400 nm) and a few largeraggre-
unmodified counterparts), polyribonucleotides such as gates (size > 10 mm; data not shown). These microag-
poly I and poly G, anionic polysaccharides such as dex- gregates exhibited green fluorescence when incubated
tran sulfate and fucoidan, and other molecules (Krieger with thioflavin T, which is characteristic for b-amyloid
and Herz, 1994). Furthermore, ligands for the SR have (Burdick et al., 1992; Cotman et al., 1992). Longer aggre-
been reported to activate some signaling pathways in gation times of up to 2 days did not significantly increase
macrophages (Johnson et al., 1982; Johnston et al., the size or amount of the aggregates as seen by optical
1987; Palkama, 1991). It has been reported that in mac- microscopy and did not affect uptake by microglia.
rophages, ligation of SR by oxidized LDL initiates a per-
tussis toxin–sensitive signaling pathway, which involves
hydrolysis of PIP2 and which can suppress expression of Microglia Internalize Cy3-Labeled Ab
the tumor necrosis factor a (TNFa) gene by modulating Microaggregates into the Same
activation of NFkB (Shackelford et al., 1995). Vesicles as a2Macroglobulin
To address the question of Ab removal and clearance, To study the interactions between microglia and Ab, we
we examined whether microglia of the mouse CNS are added synthetic Ab microaggregates to mouse micro-
capable of internalizing Ab microaggregates. Using an glia primary cultures. When adherent microglia were
in vitro model in which Ab is added to cell culture media,
incubated with Cy3-labeled 1–42 Ab microaggregates,
we found that primary cultures of murine microglia inter-
we found the microglia rapidly internalized the Ab parti-
nalize aggregates of labeled Ab peptide (1–42). We pre-
cles. Microglia became brightly labeled by a 10 min
sent evidence that ligands for the macrophage SRs ef-
incubation with 1 mg/ml Cy3-Ab microaggregates (Fig-fectively compete with Ab particles for binding to the
ure 1a). Microglia took up the fluorescent Ab micro-SR, indicating that the SR plays a major role in the
aggregates into discrete vesicles, visible as punctatebinding and internalization of Ab by microglia.
fluorescence distributed throughout the cell. About
80%–90% of the cells showed uptake of fluorescent
microaggregates, although the level of uptake variedResults
among cells. Both ameboid and ramified microglia inter-
nalized Cy3-labeled Ab microaggregates. Ramified mi-Preparation of b-Amyloid Microaggregates
croglia had bright punctate fluorescence all along theirThe kinetics of Ab fibril assembly and insoluble aggre-
long processes.gate formation are dependent on many factors, such as
To characterize the compartments containing Cy3-Ab fragment length, solution pH, peptide concentration,
Ab, microglia were incubated with it and FITC-labeledincubation time, presence of organic solvents, seeding,
a2Macroglobulin (a2M), which follows a typical pathwayand ionic strength (Burdick et al., 1992; Cotman et al.,
of receptor-mediated endocytosis into endosomes and1992; Snyder et al., 1994). Ab 1–42 has been shown to
then lysosomes (Yamashiro and Maxfield, 1987). Weaggregate much more rapidly than Ab 1–40 or shorter
found that Cy3-labeled Ab is taken up into the samepeptides (Snyder et al., 1994), and both the rate and
vesicles as a2M, indicating that the Ab microaggregatesextent of assembly are much higher at pH 5.0 than at
pH 7.4. Because it was previously reported that the 1–42 rapidly enter endosomes (Figures 1a and 1b). At longer
Microglial Uptake of Amyloid Plaque Peptides
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Figure 1. Microglia Internalize Cy3-Labeled
Ab Microaggregates into the Same Vesicles
as FITC-a2M
Cy3-Ab microaggregates (1 mg/ml final con-
centration) were formed as described in Ex-
perimental Procedures. FITC-labeled a2M
was then added to the medium containing
Cy3-Ab microaggregates, and this medium
was added to microglia isolated from mixed
glial cultures with 12 mM lidocaine. After 10
min at 378C, the cells were rinsed, fixed, and
visualized by fluorescence microscopy for
Cy3-Ab (a) and FITC-a2M (b). White arrows
indicate examples of colocalization of the in-
ternalized Ab and a2M. With the selective filter
sets used for fluorescence microscopy, there
is no detectable crossover of Cy3 into the
FITC image,or vice versa. Thus, the extensive
overlap of the two labels represents cointer-
nalization of Cy3-Ab and FITC-a2M into the
same endosomes. Using negative stain, elec-
tron microscopic observation revealed ag-
gregates ranging up to several microns in
diameter (c). Higher magnification of aggre-
gates ([d], corresponding to boxed area in [c])
demonstrated the presence of 10 nm fibrils
(black arrows). Scale bars, 10 mm (a and b);
500 nm (c); and 50 nm (d).
incubation times (30–60 min), bothCy3-Ab and a2M fluo- cells incubated with Ab, fixed but not permeabilized,
showed some surface labeling of Ab antibody (Figurerescence becomes increasingly concentrated in organ-
elles around the nucleus (data not shown), consistent 2b), but the labeling was significantly less than in the
permeabilized cells (Figure 2a). This indicates that mostwith delivery to late endosomes and lysosomes.
To examine the mechanism of Ab microaggregate up- of the microaggregates of unlabeled Ab are internalized
by microglia, similar to the internalization observed withtake by microglia, we tested whether the internalization
could be saturated. We found that microglia incubated Cy3-Ab.
for 15 min with increasing Cy3-Ab microaggregate con-
centrations showed progressively brighter internal fluo-
rescent labeling up to a concentration of about 50 mg/ Receptor-Associated Protein, a 39 kDa
Lipoprotein Receptor–Related Proteinml. Microglia incubated with Cy3-Ab microaggregate
concentrations higher than 50 mg/ml showed no in- Antagonist, Did Not Block Ab Uptake
Since microglia take up activated a2M, which is a ligandcrease in internal labeling (data not shown). This sug-
gested that the Cy3-Ab microaggregate uptake is satu- for a multifunctional receptor, the lipoprotein receptor–
related protein (LRP), we investigated whether this re-rable and is not fluid-phase internalization.
ceptor was responsible for uptake of Ab microaggre-
gates by microglia. Kounnas et al. (1995) had foundMicroglia Internalize Unlabeled Ab Microaggregates
Labeling a protein with a fluorescent dye may alter its that the secreted form of bAPP containing the Kunitz
protease inhibitor domain is internalized and degradedinteraction with receptors (Maxfield, 1989). To verify that
microglia could internalize unmodified Ab microaggre- by mouse embryonic fibroblasts via LRP, and the uptake
can be blocked by the receptor-associated proteingates, we incubated microglia for 30 min with different
concentrations of unlabeled Ab microaggregates and (RAP). RAP is a 39 kDa LRP antagonist that binds LRP
at several sites and blocks ligand-binding activity (Herzthen visualized the Ab by immunostaining with a mono-
clonal antibody against Ab peptide. We found that mi- et al., 1991).
We incubated microglia with up to 80 mg/ml RAP forcroglia were able to internalize microaggregates of un-
modified Ab (Figure 2a). The uptake looked somewhat 60 min, then added medium containing both Cy3-Ab
microaggregates and RAP. We found that the uptake ofdifferent from that of Cy3-labeled Ab; unlabeled Ab
seemed to form larger microaggregates than Cy3-Ab, Cy3-Ab was not affected by RAP (data not shown). Simi-
lar experiments were performed using unlabeled Ab andand the Ab associated with the microglia was often in
larger particles. The basis for the difference in aggregate RAP, where internalized Ab was detected by immuno-
staining. RAP had no significant effect on unlabeled Absize is not known.
To verify that the Ab microaggregates had actually uptake (Figures 3a and 3b). We also tried blocking Cy3-
Ab uptake by coincubation with excess unlabeled a2Mbeen internalized by the microglia and were not just
sticking to the cell surface, we incubated two sets of and found that concentrations of up to 1 mg/ml activated
a2M did not compete with Ab binding (data not shown).cells with Ab microaggregates. Before labeling the cells
with the anti-Ab antibody, we permeabilized one set and Therefore, LRP binding was not required for Ab uptake
by microglia.not the other with 0.1% Triton X-100. We found that
Neuron
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Excess Ac–LDL and Fucoidan Block Uptake
of Ab Microaggregates
Because the macrophage SRs are known to bind a wide
variety of ligands (Goldstein et al., 1979; Krieger et al.,
1993; Krieger and Herz, 1994), it seemed possible that
SRs, in microglia, were mediating the binding and inter-
nalization of both Ac–LDL and Ab microaggregates.
We verified that our microglial cultures bound and
internalized Ac–LDL saturably. Cells incubated with 5
mg/ml DiI-Ac–LDL (Ac–LDL labeled with the fluorescent
lipid analog, DiI) showed intense labeling of endosomes
(Figure 4a), which was competed by a 40-fold excess
of unlabeled Ac–LDL (Figure 4b). We then examined the
effect of excess Ac–LDL on uptake of Cy3-Ab microag-
gregates. We incubated microglial cultures for 20 min
at 378C with labeling medium (Figure 4c) or 200 mg/ml
Ac–LDL (Figure 4d), then continued the incubation for an
additional 10 min with 2 mg/ml Cy3-Ab microaggregates.
We found that the binding and uptake of Cy3-Ab mi-
croaggregates were blocked by excess Ac–LDL, sug-
gesting that Cy3-Ab and Ac–LDL arebinding to thesame
receptor, probably one of the SRs. As described below,
this concentration of Ac–LDL did not affect the uptake
of Cy3-labeled transferrin (Tf) by microglia (see Fig-
ure 7).
There are two class A SR isoforms, type I and type II,
that are generated by alternative splicing of a message
encoded by a single gene. Macrophages express both
types of SR-A in vitro and in vivo. Type II SR-As differ
from type I receptors only in that they lack the 110-
residue cysteine-rich C-terminal domain found on type
I receptors. The type II SR-A exhibits similar high affinity
broad-specificity ligand binding as type I SR-As (Krieger
and Herz, 1994). Both types of SRs bind Ac–LDL, and
the binding can be competed with excess M-BSA or by
anionic polysaccharides such as fucoidan and dextran
sulfate. Recently, another class of SR has been charac-
terized, called a class B SR, which has different ligand
binding properties from the type I and II receptors and
is a member of the CD36 family of membrane proteins
(Acton et al., 1994; Freeman et al., 1991; Penman et al.,
1991; Rigotti et al., 1995). These receptors areexpressed
primarily in fat, lung, liver, and nonplacental steroido-
genic tissues. They bind native LDL, chemically modified
LDL, M-BSA, and high density lipoproteinwith high affin-
ity, but polyanion binding is weaker than to class A SRs
(Acton et al., 1996). The binding of Ac–LDL to type B
SRs can be effectively blocked by low doses of M-BSA.
Ligands for the type A SRs, such as fucoidan and
dextran sulfate, effectively blocked DiI-Ac–LDL uptake
in microglia. Concentrations of 500 mg/ml of either fu-
Figure 2. Microglia Internalize Unlabeled Ab Microaggregates
coidan (Figure 4f) or dextran sulfate (data not shown)
Microglia were incubated with unlabeled Ab microaggregates, then
were effective at blocking DiI-Ac–LDL uptake by mi-processed for immunofluorescence. Two sets of microglial cultures
croglia.were incubated with Ab microaggregates (20 mg/ml) at 378C for 30
Excess fucoidan also competed for uptake of Cy3-min and then fixed. One set of cells was then permeabilized with
0.1% Triton X-100 for 20 min at room temperature, while the other Ab microaggregates. Microglia were incubated with 1
set was incubated in medium 1. Both sets were then processed mg/ml Cy3-Ab in the absence or presence of fucoidan
for immunofluorescence as described in Experimental Procedures. (Figures 4g and 4h). We found that fucoidan (500 mg/
Cells incubated with Ab microaggregates and permeabilized with ml) blocked Cy3-Ab uptake (Figure 4h) as effectively as
0.1% Triton X-100 are shown in (a), and the unpermeabilized cells
it blocked DiI-Ac–LDL uptake. Dextran sulfate had aare shown in (b). A phase contrast image of the cells shown in (b)
similar effect: at 500 mg/ml, it blocked internalization ofis shown in (c). Scale bar, 10 mm.
both Cy3-Ab microaggregates and DiI-Ac–LDL (data not
shown).
Microglial Uptake of Amyloid Plaque Peptides
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Figure 3. RAP Did Not Block Ab Uptake
Ab microaggregates (20 mg/ml) were formed
as described in Experimental Procedures.
Where indicated, RAP (40 mg/ml) was then
added to the medium containing Ab microag-
gregates. Cells were incubated for 5 min at
378C in the absence (a) or presence (b)of RAP
(40 mg/ml). The cells were then incubated for
30 min with Ab microaggregates in the ab-
sence (a) or presence (b) of RAP. The cells
were then rinsed, fixed, and permeabilized.
The Ab was detected by immunofluores-
cence as described in Experimental Proce-
dures. Scale bar, 20 mm.
We also examined the uptake of 125I-labeled Ab mi- was blocked by coincubation with excess Ac–LDL, fu-
croaggregates by microglia. As shown in Figure 5, up- coidan, or M-BSA. These competitive inhibitors did not
take of the labeled microaggregates (1 mg/ml) was inhib- block the uptake of 125I-Tf by a CHO cell line transfected
ited by Ac–LDL (10 mg/ml), fucoidan (10 mg/ml), or with the human Tf receptor (Figure 8b). 125I-Tf binding
M-BSA (10 mg/ml). specificity was checked by control experiments where
It is known that SRs bind with high affinity to certain the incubation medium contained excess unlabeled di-
proteins that have been chemically modified, such as ferric Tf. Although all three competitive inhibitors signifi-
Ac–LDL, oxidized LDL, or M-BSA, but do not bind their cantly decreased Ab uptake, some were more effective
unmodified counterparts. We therefore checkedthat un- competitors than others. The class B SR–mediated up-
modified Ab microaggregates could also be internalized take of 125I-labeled Ab microaggregates was more effec-
by microglia in the same way that the modified forms tively blocked by Ac–LDL and M-BSA than it was by
of Ab microaggregates were internalized. We incubated excess fucoidan, whereas class A SR–mediated uptake
microglia with 20 mg/ml unlabeled Ab microaggre- was more effectively blocked by Ac–LDL and fucoidan
gates mixed with increasing amounts of Ac–LDL. The than by M-BSA.
uptake of Ab was then detected by immunofluores-
cence. As shown in Figures 6c and 6d, Ac–LDL signifi-
Excess Unlabeled Ab Microaggregates Werecantly blocked the uptake of unlabeled Ab microaggreg-
Effective at Blocking DiI-Ac–LDL Uptakeates when compared to control cells (Figure 6a).
To verify that the Ab microaggregates were binding toFurthermore, the effect of Ac–LDL is nearly maximal at
the same SR receptor as Ac–LDL, we tested whether50 mg/ml (compare Figure 6c and Figure 6d). Ab uptake,
Ab particles could block DiI-Ac–LDL binding to the SR.like Ac–LDL and Cy3-Ab uptake, is effectively blocked
Microglia were incubated for 30 min at 378Cwith labelingby 500 mg/ml fucoidan (Figure 6b) or 500 mg/ml dextran
medium containing either BSA (Figure 9a), 100 mg/mlsulfate (data not shown).
Ac–LDL (Figure 9b), or Ab microaggregates at concen-We quantified the competition of Ab uptake by mea-
trations from 100–500 mg/ml (Figures 9c and 9d). DiI-suring the total fluorescence power per cell from the
Ac–LDL at a concentration of 1 mg/ml was then added toexperiments shown in Figures 4 and 6 using digital im-
age analysis as described in Experimental Procedures each of the different media already containing Ac–LDL,
(Figure 7). The data show significant inhibition of both BSA, or Ab microaggregates, and the cells were incu-
Cy3-Ab and unlabeled Ab uptake by excess Ac–LDL bated for an additional 10 min. We found that Ab mi-
and fucoidan. These same concentrations of Ac–LDL croaggregates reduced DiI-Ac–LDL uptake in a dose-
had no effect on Cy3-labeled Tf uptake by microglia dependent manner. At 500 mg/ml, Ab microaggregates
(Figure 7). reduced DiI-Ac–LDL uptake as effectively as 100 mg/ml
Recently, CHO cell lines expressing the hamster class Ac–LDL.
B SRs (haSR-B1) or the type I or type II murine class A
SRs (mSR-AI and mSR-AII) have been created (Acton
Discussionet al., 1994; Ashkenas et al., 1993; Rigotti et al., 1995).
We examined the uptake of 125I-labeled Ab microaggre-
The presence of activated microglia within amyloidgates by these cellsand the untransfected parental CHO
plaque cores has led to proposals that microglia maycells. As shown in Figure 8a, expression of either type
contribute to the formation of the plaques (WisniewskiI or type II class A SR significantly increased the uptake
et al., 1990) or that they maybe engaged inphagocytosisof Ab microaggregates compared to the parental CHO
of the amyloid fibers or aggregates to clear them. Therecell line. Furthermore, this uptake was blocked by ex-
have been several immunohistochemical analyses char-cess Ac–LDL, fucoidan, or M-BSA (Figure 8a). The ex-
acterizing the relationship between plaque microgliapression of the hamster class B SR also increased up-
take of 125I-labeled Ab microaggregates, and the uptake and amyloid fibrils (Frackowiak et al., 1992; McGeer et
Neuron
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Figure 4. SR Ligands Block Cy3-Ab Uptake
by Microglia
Microglia were incubated for 10 min at 378C
in labeling medium (with 2 mg/ml ovalbumin)
with either Cy3-Ab microaggregates or DiI-
Ac–LDL. Where indicated, cells were incu-
bated with competing ligands before and dur-
ing the addition of the labeled ligands. The
cells were then rinsed, fixed, and viewed by
fluorescence microscopy. Microglia were in-
cubated with 5 mg/ml DiI-Ac–LDL (a), 5 mg/ml
DiI-Ac–LDL 1 200 mg/ml Ac–LDL (b), 2 mg/
ml Cy3-Ab (c), 2 mg/ml Cy3-Ab 1 200 mg/ml
Ac–LDL (d), 20 mg/ml DiI-Ac–LDL (e), 20 mg/
ml DiI-Ac–LDL 1 500 mg/ml fucoidan (f), 1
mg/ml Cy3-Ab (g), and 1 mg/ml Cy3-Ab 1 500
mg/ml fucoidan (h). The cells shown in (a)–(d)
are from matched incubations carried out in
one experiment, and the cells in (e)–(h) are
from a similar matched set in a separate ex-
periment. Scale bar, 10 mm.
al., 1988; Perlmutter et al., 1990; Wisniewski et al., 1990), beled Ab (Figures 6 and 7), and measurements of cell-
associated radioactivity after incubation with radiola-and more recently, it was shown that rat microglia,
astrocytes, and a human THP-1 monocyte cell line could beled Ab (Figures 5 and 8). Finally, Ab microaggregates
were able to block uptake of DiI-Ac–LDL (Figure 9), con-degrade Ab 1–42 added to the culture medium (Shaffer
et al., 1995). However, there has been no characteriza- firming that both Ac–LDL and Ab microaggregates com-
pete for the same receptor.tion of the mechanism of clearance of Ab aggregates
or the receptors involved. The uptake of Ab via an SR may play a role inclearance
of Ab, which is produced continuously in normal andThe data presented in this paper show that murine
microglia can internalize Ab microaggregates. We have AD brains (Golde et al., 1993; Haass et al., 1991; McGeer
et al., 1992). Both the LRP (Rebeck et al., 1993) andpresented several types of evidence that are all consis-
tent with saturable uptake of Ab microaggregates to a the macrophage SR are expressed on microglia in the
human brain. The SR is not expressed on astrocytes,SR. Internalization of Ab microaggregates is saturable,
and four ligands for the SR, Ac–LDL, fucoidan, M-BSA, neurons, or vessel-associated structures. In AD, there
is a strong expression of the SR on activated microgliaand dextran sulfate, are each able to block the uptake
of Ab microaggregates by microglia as well as by CHO in the vicinity of senile plaques (Christie et al., 1996). It
has also been found that in the brain, microglia willcell lines expressing an SR. The inhibition could be dem-
onstrated by direct observation of internalized Cy3-Ab express the SR in response to different forms of injury
in the CNS (Bell et al., 1994).(Figures 4 and 7), immunofluorescent detection of unla-
Microglial Uptake of Amyloid Plaque Peptides
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Figure 5. Binding of 125I-Labeled Ab Microag-
gregates by Microglia Is Inhibited by Excess
Ac–LDL, Fucoidan, or M-BSA
Microglia were incubated for 2 hr at 378C with
labeling medium (DMEM containing 10 mg/
ml BSA) and 1 mg/ml 125I-labeled Ab microag-
gregates alone or with medium containing
both Ab microaggregates and 10 mg/ml either
Ac–LDL, M-BSA, or fucoidan. After the incu-
bations, unbound ligand was removed with
three washes of labeling medium. The cells
were chased for 30 min, then rinsed again,
solubilized, and cell-associated 125I-labeled
Ab was measured. A background of 125I-
labeled Ab sticking to wells with no cells was
subtracted from the total counts (which was
less than 10% of control binding). The data
shown are an average of the radioactivity in
three wells per condition from a representa-
tive experiment. Error bars show SEM.
Although LRP is expressed on microglia, it is not in- variety of modified proteins. The class A SRs contain a
cluster of positively charged residues in their collage-volved in the uptake of Ab 1–42 microaggregates by
microglia. The internalization of both labeled and un- nous domain that are highly conserved and may provide
sticky surfaces that function as “molecular flypaper” formodified Ab microaggregates by microglia was not sig-
nificantly affected by coincubation with RAP or excess high affinity binding (Krieger and Herz, 1994). However,
in general the exact determinants that confer bindinga2M (Figure 3). We cannot rule out a minor component
of Ab uptake by LRP, but the effect of competing ligands ability upon SR ligands have not been identified yet.
SR ligand binding is complex not only because of itsfor LRP is small if compared to the robust reduction in
uptake seen when microglia were incubated with excess broad specificity, but also because it exhibits nonrecip-
rocal cross-competition (i.e., one ligand efficiently com-Ac–LDL and Ab microaggregates.
Ligand binding to SRs is characterized by high affinity petes for the binding of a second ligand while the second
ligand only partially competes for the binding of the first)and broad specificity. All types of SRs recognize a wide
Figure 6. Excess Ac–LDL and Fucoidan
Competitively Inhibit Uptake of Unlabeled Ab
Microaggregates
Microglia (isolated with 12 mM lidocaine)
were preincubated in labeling medium for 15
min at 378C with either 1 mg/ml BSA (a), 500
mg/ml fucoidan (b), 50 mg/ml Ac–LDL (c), or
500 mg/ml Ac–LDL (d). The cells were then
incubated for a further 30 min with unlabeled
Ab microaggregates with the same additions
as in the preincubation. The cultures were
then rinsed, fixed, and permeabilized, and the
Ab microaggregates were detected by immu-
nofluorescence. Each of the competing li-
gands effectively blocked uptake of Ab mi-
croaggregates. Scale bar, 20 mm.
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Ab clearance in the brain. Nevertheless, the possibility
of Ab microaggregate uptake by SR-B or other SRs
cannot be completely ruled out.
We have demonstrated that microglia are capable of
rapid internalization of small Ab microaggregates and
that these microaggregates enter the same endosomes
as a2M, suggesting that, in microglia, Ab microaggre-
gates are delivered to late endosomes and lysosomes.
We found that smaller Ab particles were readily internal-
ized, whereas the larger particles were usually found
bound to the surface of the cells at the end of 10–30
min incubations. Further experiments will be required
to determine whether microglia are not capable of taking
up large Ab particles or cannot internalize the larger
particles in the relatively short incubation time we used
in this study. In AD brain tissue, activated microglia are
found around plaques that are much larger than the Ab
microaggregates used in these experiments, and these
plaques contain other proteins besides Ab, such as
apolipoprotein E (Schmechel et al., 1993). It is not known
if microglia are capable of internalizing and degrading
plaque in the brain.
Because activated microglia, which are the main in-Figure 7. Excess Ac–LDL and Fucoidan Competitively Inhibit Up-
take of Both Unlabeled and Cy3-Labeled Ab Microaggregates But flammatory response cells of the brain, are enriched
Do Not Block Tf Uptake by Microglia around amyloid plaques, it has been proposed that
We performed a quantitative analysis of the competitive binding plaques are sites of chronic inflammation. There have
experiments shown in Figures 4 and 6 as described in Experimental been reports that Ab can activate microglia and trigger
Procedures. Fluorescence power was determined for at least 20 the production of proinflammatory and potentially cyto-
cells per field in ten fields per condition. The data shown are mean
toxic mediators (Araujo and Cotman, 1992; Meda et al.,values 6 SEM from a representative experiment. The values shown
1995). Meda et al. (1995) found that Ab (25–35) togetherare normalized against the condition with the highest fluorescence
with interferon-g can trigger the production of reactiveper cell. Microglia were incubated with unlabeled Ab microaggre-
gates (20 mg/ml) alone or in the presence of fucoidan (500 mg/ml) nitrogen intermediates and TNFa from cultured micro-
or Ac–LDL (50 mg/ml). Microglia were also incubated with Cy3 Ab glia and that this leads to neuronal cell injury in vitro.
microaggregates (10 mg/ml), or with both Cy3 Ab microaggregates Ab 1–42enhances microglial release of interleukin-1 and
and Ac–LDL (200 mg/ml). All of the competitors caused a significant
basic fibroblast growth factor (Araujo and Cotman,reduction in fluorescence power (p < 0.001) by t test. To confirm
1992).that inhibition of uptake of Ab by Ac–LDL was specific, microglia
It is possible that by binding to SRs, ligands maywere incubated with Cy3-labeled Tf (20 mg/ml) or Cy3 Ab in the
presence or absence of 200 mg/ml Ac–LDL. Columns are from left transmit a signal and regulate cellular metabolism. There
to right: microglia incubated with 20 mg/ml unlabeled Ab microag- are reports that binding to SRs activates signaling path-
gregates alone (cntrl), Ab microaggregates and 500 mg/ml fucoidan ways in macrophages (Johnson et al., 1982; Johnston
(Fc), Ab microaggregates and 50 mg/ml Ac–LDL (Ac–LDL); 10 mg/
et al., 1987; Palkama, 1991), and it was reported thatml Cy3 Ab microaggregates, Cy3 Ab microaggregates with 200 mg/
oxidized LDL binding to a SR initiates a pertussis toxin–ml Ac–LDL (Ac–LDL); 20 mg/ml Cy3 Tf, and Cy3 Tf with 200 mg/ml
sensitive signaling pathway, which involves hydrolysisAc–LDL. Error bars give the SEM.
of PIP2 and which can suppress expression of the
TNFa gene by modulating activation of NFkB (Shackel-
(Freeman et al., 1991; Krieger, 1992). This might be due ford et al., 1995). Several treatments have been reported
to the presence of multiple binding sites on a single to affect SR activity in cultured macrophages. These
receptor or multiple receptor conformations with differ- include phorbol esters, endotoxin, poly[I:C], macro-
ent binding properties or even to the expression of other phage colony–stimulating factor, platelet secretory
classes of SR other than class A and B. products, conditioned medium from stimulated lympho-
We found that both class A and class B SRs could cytes, transforming growth factor b1, interferon-g, reti-
mediate uptake of radiolabeled Ab microaggregates by noic acid, and dexamethasone (Krieger and Herz, 1994).
transfected CHO cells (Figure 8). Uptake of Ab microa- There have been many studies on the role of excess
ggregates by microglia was blocked well by all SR li- production of Ab in the formation of plaques in the AD
gands tested (Ac–LDL, fucoidan, dextran sulfate, and brain. Amyloid deposition and accumulation may de-
M-BSA). Class A SRs are expressed on macrophage- pend, however, not only on the rate of Ab synthesis, but
like cells, including microglia (Christie et al., 1996; also on the rate of its removal. Excess synthesis of Ab
Krieger and Herz, 1994), but class B SRs are expressed aggregates may overwhelm the capacity of microglia to
primarily in liver, ovary, and adrenal gland. Some expres- remove them. Alternately, since the expression of SR-A
sion of mSR-B was also found in testis, mammary gland, by microglia is regulated, under certain conditions, inad-
and heart, but there was little expression in brain (Acton equate clearance could occur if insufficient SR were
et al., 1996). Based on the tissue distribution, it seems available to clear Ab. This could lead to accumulation of
amyloid even if the rate of production was not increased.likely that SR-A is the SR that plays a significant role in
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Figure 8. 125I-Labeled Ab Microaggregates
Are Bound and Taken Up by CHO Cells
Transfected with Either the Murine Class A
or the Hamster Class B SR
(a) CHO cells were incubated for 2 hr at 378C
with labeling medium with 1 mg/ml 125I-labeled
Ab microaggregates alone or with medium
containing both Ab microaggregates and 10
mg/ml either Ac–LDL, M-BSA, or fucoidan.
After the incubations, unbound ligand was
removed with three washes of labeling me-
dium. The cells were chased for 30 min, solu-
bilized with 1 N NaOH, and cell-associated
125I-labeled Ab was measured. From left to
right: CHO parental cell line incubated with
1 mg/ml 125I-labeled Ab microaggregates;
CHO cells transfected with mSRA-I incubated
with 1 mg/ml 125I-labeled Ab microaggregates
alone or with 10 mg/ml Ac–LDL, fucoidan, or
M-BSA; CHO cells transfected with mSRA-II
incubated with 1 mg/ml 125I-labeled Ab mi-
croaggregates and these same inhibitors;
CHO cells transfected with haSRA-B1 incu-
bated with the same inhibitors; ldlA7 parental
cell line incubated with 1 mg/ml 125I-labeled
Ab microaggregates.
(b) For Tf uptake, TRVb1 cells were incubated
with 125I- Tf in iron-poor medium (McCoy’s
5A medium) for 30 min, rinsed six times with
incubation medium, and solubilized with 1 N
NaOH. Cell associated 125I-labeled Tf was
counted. The incubation medium contained
either 125I-labeled Tf (1 mg/ml) alone or with
200 mg/ml of unlabeled diferric Tf, Ac–LDL,
fucoidan, or M-BSA.
The data presented are averages of the radio-
active counts from three dishes per condition
from a representative experiment. Error bars
give the SEM.
Experimental Procedures cultures could then be shaken every 3–4 days for 2 to 3 weeks.
Microglia were harvested by orbital shaking for 20 min in DMEM or,
where noted, in DMEM with 12 mM lidocaine (Sigma, St. Louis, MO).Isolation of Microglia
We prepared primary cultures of mixed glia from newborn mice and Cells were centrifuged for 10 min at 1450 RPM and plated onto 35
mm diameter plastic tissue culture dishes whose bottoms had beenthen isolated the weakly adherent microglia from cell monolayers
according to a previously described method (Nakajima et al., 1989; replaced with poly-D-lysine-coated No. 1 glass coverslips (Salzman
and Maxfield, 1988) at a density of 104–105 cells/coverslip. ShakingGiulian and Baker, 1986). We obtained neocortical tissues of new-
born mice, removed the meninges, minced, and incubated the tis- one 75 cm2 flask of mixed glial cultures usually yielded enough
microglia for ten coverslips. For 125I-Ab uptake experiments, micro-sues in 2.5% trypsin (Worthington Biochemical Corporation, Free-
hold, New Jersey) and 0.01% deoxyribonuclease I (DNase) glia were plated on poly-D-lysine-coated 24 well trays at the same
density (105 cells/well).(Worthington) in phosphate-buffered saline (PBS) for 3 min at 378C.
The tissue was triturated with fire-polished pipets in 0.1 mg/ml We used the uptake of DiI-Ac–LDL by microglia to assess the
purity of our microglial cultures, because microglia, unlike astrogliaDNase in Dulbecco’s modified Eagle’s medium (DMEM) (Gibco Lab-
oratories, Grand Island, NY) with 10% fetal bovine serum (FBS) or oligodendroglia, have the Ac–LDL receptor (Giulian and Baker,
1986). Over 95% of the cells harvested after shaking and lidocaine(Gibco). The cells were centrifuged for 5 min at 350 g, and the
pellet was resuspended in DMEM with 10% FBS and penicillin/ treatment took up DiI-Ac–LDL.
After a day in culture, the cells exhibited two predominant mor-streptomycin. The supernatant was passed through a 145 mm mesh,
recentrifuged for 5 min, resuspended, passed through a 33 mm phologies, an elongated ramified form and an ameboid form. Rami-
fied cells are generally viewed as resting or quiescent microglia thatmesh, and centrifuged one more time. Cells were resuspended in
growth medium then plated in 75 cm2 flasks coated with poly-D- lack phagocytic properties (Giulian and Baker, 1986), but we found
the two cell types did not differ in their ability to bind and take uplysine at a density of about 1.5–2.0 3 107 cells per flask (about five
cortices per flask). The mixed glial cultures were grown in bicarbon- DiI-Ac–LDL.
ate-buffered DMEM supplemented with 10% FBS, 100 units/ml peni-
cillin, and 100 mg/ml streptomycin (Gibco) at 378C in a 5% CO2 CHO Cell Lines
Cell line pJA 28-C5, expressing the murine class A type 1 SR(mSR-humidified air atmosphere. The mixed glial cultures were grown for
1 week before microglia were collected from the flasks. Mixed glial AI) (Ashkenas et al., 1993), cell line pJA 22–1 C8, expressing the
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Figure 9. Unlabeled Ab Microaggregates
Block DiI-Ac–LDL Uptake
Ab microaggregates were prepared at con-
centrations from 50–500 mg/ml. Ac–LDL was
diluted to a concentration of 100 mg/ml. Mi-
croglia were incubated for 30 min at 378C with
labeling medium containing either Ac–LDL
(b), Ab microaggregates (c–d) or BSA (a). DiI-
Ac–LDL at a concentration of 1 mg/ml was
then added to each of the different media and
the cells were incubated for an additional 10
min. The cells were then rinsed, fixed, and
viewed by fluorescence microscopy. Bar,
20 mm.
(a) DiI-Ac–LDL 1 BSA.
(b) DiI-Ac–LDL 1 100 mg/ml Ac–LDL.
(c) DiI-Ac–LDL 1 100 mg/ml Ab.
(d) DiI-Ac–LDL 1 500 mg/ml Ab.
murine class A type II SR (mSR-AII), cell line ldlA[haSR-B1]-1, ex- Systems, Inc.) according to the instructions of the manufacturer.
Fucoidan and dextran sulfatewere from Sigma. RAP was generouslypressing the hamster class B type 1 receptor (Acton et al., 1994;
Rigotti et al., 1995), as well as the parental cell lines, CHO and ldlA7, provided by Dr. I. Goldberg (Columbia University, NY).
For all our studies on the uptake of Cy3-labeled Ab and unlabeledwere generously provided by Dr. M. Krieger (MIT, Cambridge, MA).
For measurements of Tf uptake, TRVb1 cells were used. This cell Ab microaggregates, the peptide was preaggregated before being
added to microglial cultures. Ab was initially diluted in water whileline is derived from the TRVb CHO cell line, which lacks endogenous
hamster Tf receptors. TRVb1 cells have been stably transfected with vortexing, mixed well, then further diluted in labeling medium
(serum-free DMEM medium without bicarbonate, buffered with 20a wild-type human Tf receptor (McGraw et al., 1987). All cell lines
were grown in Ham’s F-12 balanced salt solution with bicarbonate mM HEPES to pH 7.4, and containing 100 units/ml penicillin and
100 mg/ml streptomycin). Labeling medium also contained 10 mg/supplemented with 5% FBS, 100 units/ml penicillin, and 100 mg/ml
streptomycin at 378C in a 5% CO2 humidified air atmosphere. All ml BSA RIA Grade (Sigma), unless, as indicated in the figure legends,
2 mg/ml ovalbumin (Sigma) was used instead. The peptide wastransfected cells were grown in Ham’s F-12, 5% FBS, and 0.25 mg/
ml geneticin (Sigma). For fluorescence experiments, the cells were diluted slowly while vortexing, then vortexed further for 3 min. Ab
peptide was allowed to aggregate for 1 hr at room temperature, andplated on poly-D-lysine-coated coverslip dishes as described for
the microglia. For experiments with 125I-Ab, the cells were plated in Cy3-Ab was allowed to aggregate at room temperature for 15 min
before being added to microglial cultures.24 well plates 2–3 days before an experiment, so that on the day
of the experiment, the cells were at about 80% confluence.
Electron Microscopy
Proteins
For negative stain electron microscopy, either 20 mg/ml Ab or 1 mg/
1–42 b-amyloid peptide was purchased from Bachem (Torrance,
ml Cy3-Ab was dissolved in pH 7.4 buffered DMEM and allowed to
CA). The lyophilized powder was diluted in sterile water to 5 mg/ml
aggregate for 30 min. The aggregated peptide was then absorbed
and kept at 2908C. Fluorescent b-amyloid was prepared by derivat-
onto 200 mesh carbon-coated formvar grids (Electron Microscopy
izing it with Cy3, an orange fluorescing carbocyanine dye (Biological
Sciences, Inc., Fort Washington, PA), air dried, washed three timesDetection Systems Inc., Pittsburgh, PA) according to the instruc-
for 5 min by submersion in distilled water, and stained with saturated
tions of the manufacturer. 1–42 Ab was dissolved at 1 mg/ml in
aqueous uranyl acetate. Grids were observed at 80 keV using a
0.1 M sodium carbonate–sodium bicarbonate buffer (pH 9.3), then
JEOL JEM1200 EX II transmission electron microscope.
added to the Cy3 dye. The labeled protein was separated from
excess unconjugated dye by dialysis. 125I-labeled Ab was prepared
using thechloramine T method as described (Yamashiroet al., 1984). Fluorescent Labeling of Cells
All labeling was done in air at 378C. Cells were first rinsed twiceWe iodinated 100 mg of Ab in 0.05 M sodium borate buffer (pH 9.0).
The excess 125I was removed by passage over a G-15 Sephadex with dye-free labeling medium. Aggregated Cy3-Ab in labeling me-
dium was then added to the medium. Cy3-Ab was incubated withcolumn and dialysis against borate buffer for 6 hr at room tempera-
ture. The specific activity of the 125I-labeled Ab was 700 cpm/ng. microglia for varying periods of time at 378C, followed by rinsing
and fixation with 2.5% paraformaldehyde freshly diluted in mediumTf was iodinated using the same chloramine T method (Yamashiro
et al., 1984) and was provided by Dr. T. McGraw. The specific activity 1 (150 mM NaCl, 20 mM HEPES, 1 mM CaCl2, 5 mM KCl, 1 mM
MgCl2 [pH 7.4]). To study Ac–LDL uptake, the cells were incubatedof 125I-labeled Tf was 377 cpm/ng. Iron-saturated Tf was prepared
from apo-Tf as described (Yamashiroet al., 1984) andfurther purified in the same way with DiI-Ac–LDL in labeling medium. For Cy3-
labeled Tf studies, the day before Tf uptake was measured, theby passage over a S-300 HR column.
Ac–LDL was prepared by acetylation of LDL with acetic anhy- medium was replaced with iron-poor medium (McCoy’s 5A medium
with bicarbonate supplemented with 10% FBS, 100 units/ml penicil-dride as described previously (Goldstein et al., 1979) and provided
by Dr. I. Tabas (Columbia University, NY). Ac–LDL was labeled lin, and 100 mg/ml streptomycin) with 4 mM deferoxamine mesylate
(Sigma) to chelate the iron. Cells were then incubated with labelingwith 1,19-dioctadecyl-3,3,39,39-tetramethylindocarbocyanine-per-
chlorate (DiI) (Molecular Probes, Eugene, OR) according to Pitas et medium (DMEM with 10 mg/ml BSA) in the presence or absence of
the various competitors for 30 min, as described above. Cy3-Tf oral. (1981). a2M was purified, converted to the receptor-binding form,
and conjugated to either fluorescein isothiocyanate as previously Cy3-Ab microaggregates were added, and the cells were incubated
for a further 15 min. Cells were rinsed six times and fixed.described (Salzman and Maxfield, 1989) or Cy3 (Biological Detection
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Uptake of 125I-Labeled Ligands the payment of page charges. This article must therefore be hereby
marked “advertisement” in accordance with 18 USC Section 1734Cells were grown in 24 well plates for 2–3 days before the start of
the experiment. 125I-labeled Ab (1 mg/ml) was formed into aggregates solely to indicate this fact.
as described for Cy3-Ab. The cells were washed three times with
bicarbonate-buffered labeling medium with BSAand then incubated Received March 28, 1996; revised August 28, 1996.
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